Research ArticleChemotherapy, Antibiotics, and Gene Therapy
Rationale for PARP inhibitors in combination therapy with camptothecins or temozolomide based on PARP trapping versus catalytic inhibition
Junko Murai, Yiping Zhang, Joel Morris, Jiuping Ji, Shunichi Takeda, James H Doroshow and Yves G. Pommier
Journal of Pharmacology and Experimental Therapeutics March 20, 2014, jpet.113.210146; DOI: https://doi.org/10.1124/jpet.113.210146
